Canadian Clinical Cases

Thursday January 10, 2019 | 15:00 to 15:30
Room: Pier 4&5

Learning Objectives

As a result of attending this session, participants will be able to:

  • Updates on the evolving treatment landscape of advanced prostate cancer
  • Targeting the AR Pathway in Castrate Sensitive CaP
    • Discuss Issues of timing (early vs late), intermittent vs continues
    • Review evidence for benefit from combination treatments in metastatic Castrate Sensitive PCA (eg. ADT + docetaxel, ADT + abiraterone)
  • Discuss rational for Multi-modal Considerations in Oligometastatic PCA
    • Review impact of PSMA PET scans in defining oligometastatic disease
    • Role for treatment of the primary tumour in oligometastatic disease
    • Role for metastasis directed therapy in oligometastatic disease



Canadian Clinical Cases
Dr. Joseph L. Chin, Canada
Western University, London

Canadian Clinical Cases
Tamim Niazi, Canada
McGill, Montreal

Canadian Clinical Cases
Alan So, Canada
University of British Columbia, Vancouver

© 2019 CUOS 2019